This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Stockwatch Business Reporter

The TSX Venture Exchange added 5.22 points to 552.26 Friday, ending the week up 26.7 points. David Stadnyk's halted NEX shell, Viper Gold Ltd. (VPR), expects to complete its acquisition of QuikFlo Technologies Inc., a Calgary health care company, by Oct. 30.

The shell, which has 6,577,200 shares outstanding, will issue 30 million shares to the shareholders of QuikFlo, after which Viper will change its name to QuikFlo Health Inc. The Calgary health care company is developing an image-based medical technology, using research from the University of Calgary and other institutions, to interpret scans of stroke patients for doctors. QuikFlo says its product could potentially help doctors make accurate decisions faster than current standards, noting that shorter time periods between a stroke patient entering a hospital and that patient receiving the correct treatment is correlated with positive results.

The inventors of this technology, all university professors, have completed two clinical trials so far, but there is much more to do. QuikFlo has to develop automated software that can be installed in CT scanners and then conduct multicentre clinical trials, after which it will seek approval from the provincial, national and international health care regulators. This will cost millions of dollars and take many years, but to get things started Viper will close a $500,000 private placement of two million shares at 25 cents, and then look for new investors down the road.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS